Inventor

FRICK WENDELIN

DE49 patents

⚠️ This page may combine multiple inventors who share the name “FRICK WENDELIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FRICK WENDELIN

SANOFI AVENTIS DEUTSCHLAND

Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines

1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof

1,4-benzothiepin-1,1-dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof

1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic

Aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof

Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use

Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof

Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use

Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use

Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

Phosophoinositoglycan binding proteins

Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals

Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use

Phosophoinositoglycan binding proteins

Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof

Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use

Method for isolating an intestinal cholesterol binding protein

Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use

Method for isolating an intestinal cholesterol binding protein

Method for producing 1,4-diphenyl azetidinone derivatives

Process for the preparation of diphenyl azetidinone derivatives

Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C regulation

AVENTIS PHARMA GMBH

Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use

Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use

Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals

1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use

Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use

Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals

Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use

Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use

Benzo(b)thiepine-1,1-dioxide derivatives, a method for the production thereof, medicaments containing these compounds, and their use

Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use

Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use

Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use

Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use

Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives

Combinations with statin and aryl-substituted propanolamine derivatives, their preparation pharmaceuticals comprising them, and their use

Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use

GLOMBIK HEINER

1,4-benzothiepin-1, 1-dioxide derivatives with improved properties method for producing the same, drugs containing said compounds and the use thereof

1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof

HOECHST AG

Inositolglycans having insulin-like action

Peptides with an insulin-like action

SANOFI AVENTIS DEULSCHLAND GMB

Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product

BILLEN GUENTER

Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives